~(99)Tc~m-MIBI SPECT in prediction of response to chemotherapy in patients with small cell lung cancer
10.3760/cma.j.issn.1008-6315.2010.03.029
- VernacularTitle:~(99)Tc~m-MIBI显像预测小细胞肺癌化疗疗效的临床研究
- Author:
Tao GU
;
Zhanzhao FU
;
Lixin YAO
;
Leiming GUO
;
Haixia HUA
;
Qinghuai ZHANG
- Publication Type:Journal Article
- Keywords:
Small cell lung cancer;
Technetium-99m methoxyisobutylisonitrile;
Chemotherapy
- From:
Clinical Medicine of China
2010;26(3):300-302
- CountryChina
- Language:Chinese
-
Abstract:
Objective To assess the prediction value of technetium-99m methoxyisobutylisonitrile(~(99)Tc~m-MIBI) for the effect of chemotherapy in small cell lung cancer (SCLC) patients. Methods Fifty-three patients with SCLC were divided into two groups according to the chest computed tomography (CT) examination, 39 patients in group A with complete or partial remission, and 14 patients in groups B with stable or progressive status. ~(99)Tc~m-MIBI was performed before chemotherapy. Following i. v. administration of 740 MBq ~(99)Tc~m-MIBI, SPECT imagings at 10 -30 minutes (early) and 2 -3 hours (delayed) were performed to obtain the uptake ratio of early phase tumor/normal lung tissue (ER) and the uptake ratio of delayed phase tumor/normal lung tissue (DR). The retention index (RI) was calculated as (DR-ER)/ ER × 100%. The differences of ER,DR and RI between the two groups were tested through t-test and rank sum test. Results ~(99)Tc~m-MIBI uptake was significantly higher in group A than group B: 2.33(SD:0.21) vs 2.02(SD:0.31) for the early ratio (ER) (t = -3.401, P<0.05) and 2.44(SD:0.19) vs 1.86 (SD :0.30) for the delayed ratio (DR) (t = - 6.724,P < 0.05). The median of RI in group A was signifi-cantly higher than that in group B (5.31% vs -9.26%,P <0.05). Conclusions ER,DR and RI of ~(99)Tc~m-MIBI SPECT may be helpful in predicting the response to chemotherapy in patients with SCLC.
